Liraglutide
Bottom line
The same substance costs $315 a month at its cheapest verified route and $415 at its dearest, a gap of $100 a month or $1,200 a year. Which product it is sold as changes the approved indication and the dose ceiling, not the molecule.
Last updated 2026-06-10 — every published price for this molecule
What is liraglutide, and what does it cost?
Liraglutide is sold as Saxenda, Victoza — the same active substance under different approved indications and different dose ceilings, which is why switching between them is a prescribing decision rather than a change of medication. halfrx records 2 verified routes to it, from $315 a month at Hone Health to $415 at Saxenda. Each figure is the all-in maintenance price — membership plus medication where a seller bundles them — read from that seller's own published page on the date beside it. On trial evidence the best published result for this molecule is 8% average weight loss, from the trial behind Saxenda; no head-to-head has compared it against another molecule, so that ranks a published result rather than the drug. Its FDA label lists nausea, fatigue, constipation, diarrhoea, vomiting, injection site reactions among the common reactions, each with its own page here. A compounded preparation of the same molecule is a different legal product rather than a discount on the approved one: compounding is an exemption from approval, so it carries no trial and no approved label of its own.
Every verified route, cheapest first
Products and sellers together, because the question is what the molecule costs rather than which shelf it sits on.
| Route | A month | What it is | Trial loss | Checked |
|---|---|---|---|---|
| Hone Health | $315 | provider | — | 2026-08-19 |
| Saxenda | $415 | direct from the maker | 8% | 2026-06-10, past 45 days |
The products liraglutide is sold as
1. Saxenda
The first-generation GLP-1. Daily injection, half the weight loss, largely superseded.
- A month
- $415
- Trial loss
- 8%
- FDA status
- FDA approved for chronic weight management
2. Victoza
Daily liraglutide for type 2 diabetes — the same molecule as Saxenda at lower doses. No cash price published.
- A month
- no verified price
- Trial loss
- not published
- FDA status
- FDA approved for type 2 diabetes and cardiovascular risk reduction. Weight loss is off-label use.
What every liraglutide label lists, and each on its own page
These reactions appear on the FDA label of Saxenda — the same molecule, so the same list.
- Does Saxenda make you feel sick?
- Does Saxenda make you tired?
- Does Saxenda cause constipation?
- Does Saxenda cause diarrhoea?
- Does Saxenda make you throw up?
- Does Saxenda cause injection site reactions?
Boxed warning. In rodents this molecule caused thyroid C-cell tumours at human-relevant doses. Whether it does so in people is unknown, and the label carries that as a boxed warning. It is contraindicated outright with a personal or family history of medullary thyroid carcinoma or MEN 2.
Liraglutide, answered
- What is the cheapest liraglutide?
- Hone Health at $315 a month all-in once titrated, read from its own published page on 2026-08-19. The dearest verified route to the same molecule is Saxenda at $415.
- Which products contain liraglutide?
- Saxenda, Victoza. They differ by approved indication and by dose ceiling rather than by active substance, which is why a switch between them is a prescribing decision rather than a change of medication.
- Is compounded liraglutide the same as the branded version?
- Same molecule, different legal product. Compounding is an exemption from FDA approval rather than a form of it, so a compounded preparation has no trial and no approved label of its own, and its quality is a fact about the pharmacy that mixes it. No seller on this site names that pharmacy — all eleven checked, with the pages read listed at /pharmacy.
- How much weight do people lose on liraglutide?
- 8% on average in the trial behind Saxenda, SCALE: about 8% mean weight loss over 56 weeks. That figure describes one trial population under one protocol; no head-to-head trial has compared these molecules against each other, so it ranks published results rather than the drugs.
Every price is read from the seller's own published page on the date shown; anything past 45 days without a re-check is marked stale rather than quietly aging. Label information from FDA prescribing information for SAXENDA. Information only, not medical advice.